Information  X 
Enter a valid email address

Dukemount Capital (DKE)

  Print      Mail a friend

Tuesday 30 October, 2018

Dukemount Capital

Planning Permission Granted on Second Property

RNS Number : 7458F
Dukemount Capital PLC
30 October 2018
 

30 October 2018

Dukemount Capital Plc

("Dukemount" or the "Company")

Planning Permission Granted on Second Acquisition

 

Dukemount Capital plc, the long-dated income provider and property management company is pleased to announce that this afternoon, it has been granted planning permission for a minor extension to be built on the second acquisition.

The extension was requested by Inclusion Housing and the care provider, Lifeways Group to accommodate an increase in rooms and to add office space in the property. As previously announced, this will enhance the value of the acquisition due to the increased rental payable on the property.

The architect plans and drawings for this project will appear on our website www.dukemountcapitalplc.com.

Dukemount Executive Chairman Geoffrey Dart said, "I am pleased to be able to announce a successful planning outcome on our second acquisition in North West England. I anticipate a smoother flow of updates in the coming months.

Market Abuse Regulation (MAR) disclosure

Certain statements in this announcement contain inside information for the purpose of Article 7 of EU Regulation 596/2014.

 For further information, please contact:

 

 

Walbrook PR (Media and Investor Enquiries

Tel: +44 (0) 207 933 8780

Paul Cornelius / Gary Middleton

[email protected]

 

 

Optiva Securities Ltd

Tel: +44 (0) 203 137 1906

Christian Dennis - Corporate Broker

 

Jeremy King - Corporate Broker

 

 

 

Peterhouse Corporate Finance Limited

Tel: +44 (0) 207 469 0930

Lucy Williams/Duncan Vasey

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCFDUFDSFASELS

a d v e r t i s e m e n t